Wednesday, September 13, 2017

"Carter – himself a pharmacist who owns a Georgia pharmacy – backed the 503A compounders’ effort to expand their capabilities; the FDA’s draft memo would have limited the 503A compounders’ role. Carter’s amendment was defeated 141-279."

read entire report and other updates on federal legislation here
Post a Comment